Literature DB >> 29317427

Pfizer abandons research into Alzheimer's and Parkinson's diseases.

Nigel Hawkes1.   

Abstract

Entities:  

Year:  2018        PMID： 29317427     DOI： 10.1136/bmj.k122

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

Review 1.  The involvement of microglia in Alzheimer's disease: a new dog in the fight.

Authors:  Zachery Moore; Juliet M Taylor; Peter J Crack
Journal:  Br J Pharmacol       Date:  2018-12-18       Impact factor: 8.739

2.  Insights into Structure-Activity Relationships of 3-Arylhydrazonoindolin-2-One Derivatives for Their Multitarget Activity on β-Amyloid Aggregation and Neurotoxicity.

Authors:  Rosa Purgatorio; Modesto de Candia; Annalisa De Palma; Francesco De Santis; Leonardo Pisani; Francesco Campagna; Saverio Cellamare; Cosimo Damiano Altomare; Marco Catto
Journal:  Molecules       Date:  2018-06-26       Impact factor: 4.411

3.  A Proposal to Make Biomedical Research into Alzheimer's Disease More Democratic Following an International Survey with Researchers.

Authors:  Timothy Daly; Marion Houot; Anouk Barberousse; Amélie Petit; Stéphane Epelbaum
Journal:  J Alzheimers Dis Rep       Date:  2021-08-06

Review 4.  Drug repositioning and repurposing for Alzheimer disease.

Authors:  Clive Ballard; Dag Aarsland; Jeffrey Cummings; John O'Brien; Roger Mills; Jose Luis Molinuevo; Tormod Fladby; Gareth Williams; Pat Doherty; Anne Corbett; Janet Sultana
Journal:  Nat Rev Neurol       Date:  2020-09-16       Impact factor: 42.937
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.